Overview

Hepcidin and Glucose Metabolism

Status:
Unknown status
Trial end date:
2019-11-30
Target enrollment:
Participant gender:
Summary
Gestational diabetes mellitus (GDM), defined as hyperglycemia with blood glucose values above normal but below those diagnostic of DM, and iron deficiency (ID) with or without anemia (IDA) are common during pregnancy. Both disease patterns are associated with an increased risk of complications during pregnancy and at delivery and may have a variety of negative effects on different aspects of child development. Thus, GDM and ID/IDA during pregnancy should be prevented. Whether iron supplementation with high oral doses acutely increases hepcidin during pregnancy, and whether this acute iron-induced increase in hepcidin decreases insulin sensitivity, is uncertain.
Phase:
N/A
Details
Lead Sponsor:
Swiss Federal Institute of Technology
Collaborators:
University Hospital, Zürich
Women's clinc University Hospital Zurich
Treatments:
Hepcidins